| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ARDP.201300087 |
| P698 | PubMed publication ID | 23843304 |
| P50 | author | Di Wu | Q64532738 |
| P2093 | author name string | Ping Gong | |
| Baohui Qi | |||
| Haiyan Tao | |||
| Jinying Bai | |||
| Yandan Shi | |||
| P2860 | cites work | Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic-pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihy | Q39616531 |
| Identification and synthesis of N'-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase. | Q39751438 | ||
| Toward safer processes for C-C biaryl bond construction: catalytic direct C-H arylation and tin-free radical coupling in the synthesis of pyrazolophenanthridines | Q43226335 | ||
| N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors | Q43255650 | ||
| Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains | Q44103436 | ||
| N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor | Q44388155 | ||
| Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds | Q44476042 | ||
| Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase | Q27650405 | ||
| Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities | Q27651475 | ||
| Design, synthesis, and biological evaluation of potent c-Met inhibitors | Q27651910 | ||
| Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases | Q27657708 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3 | Q28256422 | ||
| Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates | Q34088416 | ||
| Small molecule c-Met kinase inhibitors: a review of recent patents | Q34094632 | ||
| Development of c-MET pathway inhibitors | Q34198905 | ||
| c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention | Q34422211 | ||
| Structural basis of hepatocyte growth factor/scatter factor and MET signalling | Q34572895 | ||
| Progress in cancer therapy targeting c-Met signaling pathway | Q38007133 | ||
| Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors | Q39457824 | ||
| Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold | Q39526161 | ||
| Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks | Q39528185 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 596-609 | |
| P577 | publication date | 2013-07-10 | |
| P1433 | published in | Archiv der Pharmazie - Chemistry in Life Sciences | Q10533542 |
| P1476 | title | Synthesis and biological evaluation of 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazone scaffolds as selective c-Met inhibitors | |
| P478 | volume | 346 |
| Q35603900 | A rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats |
| Q38718891 | Design and Synthesis of Novel 4-Phenoxyquinolines Bearing 3-Hydrosulfonylacrylamido or 1H-Imidazole-4-carboxamido Scaffolds as c-Met Kinase Inhibitors |
| Q38765409 | Design, Synthesis, and Biological Evaluation of 4-Phenoxyquinoline Derivatives Containing Benzo[d]thiazole-2-yl Urea as c-Met Kinase Inhibitors |
Search more.